Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Asthma”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06020014
What this trial is testing

Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

Who this might be right for
Asthma
AstraZeneca 339
Post-approval studies (Phase 4)Study completedNCT00480649
What this trial is testing

Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

Who this might be right for
Asthma
GlaxoSmithKline 424
Large-scale testing (Phase 3)Study completedNCT00314574
What this trial is testing

Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)

Who this might be right for
Asthma
Genentech, Inc. 850
Not applicableStudy completedNCT01383564
What this trial is testing

Continuous Positive Airway Pressure Use in Asthma With Moderate to Severe Obstructive Sleep Apnea Patients

Who this might be right for
OSA
Chinese University of Hong Kong 101
Post-approval studies (Phase 4)Looking for participantsNCT04743791
What this trial is testing

Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

Who this might be right for
Asthma
Sally E. Wenzel MD 30
Post-approval studies (Phase 4)Study completedNCT04400318
What this trial is testing

The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

Who this might be right for
Asthma
Sanofi 109
Early research (Phase 1)Study completedNCT04307173
What this trial is testing

Study of Multiple Ascending Dose of KBL693 in Healthy Participants

Who this might be right for
Moderate to Severe Asthma
KoBioLabs 18
Not applicableUnknownNCT06771934
What this trial is testing

Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma

Who this might be right for
Allergic Asthma
Qianfoshan Hospital 60
Large-scale testing (Phase 3)Study completedNCT05813470
What this trial is testing

Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma

Who this might be right for
Allergic AsthmaUncontrolled Moderate to Severe
Cinnagen 256
Post-approval studies (Phase 4)Looking for participantsNCT06385236
What this trial is testing

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

Who this might be right for
Moderate to Severe Asthma
University of California, San Diego 120
Not applicableStudy completedNCT03344406
What this trial is testing

Evaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With Asthma

Who this might be right for
Asthma
GlaxoSmithKline 25
Testing effectiveness (Phase 2)Ended earlyNCT06376045
What this trial is testing

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

Who this might be right for
Asthma
Amgen 317
Large-scale testing (Phase 3)Study completedNCT00642122
What this trial is testing

Adults With Moderate to Severe Asthma

Who this might be right for
Asthma
AstraZeneca 900
Testing effectiveness (Phase 2)Study completedNCT05985694
What this trial is testing

AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Advagene Biopharma Co. Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07403487
What this trial is testing

Phase II Trial of RC1416 Injection in Asthma

Who this might be right for
Moderate to Severe Asthma
Nanjing RegeneCore Biotech Co., Ltd. 195
Large-scale testing (Phase 3)Study completedNCT01340209
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 285
Large-scale testing (Phase 3)Ended earlyNCT02182700
What this trial is testing

Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis

Who this might be right for
Asthma
Boehringer Ingelheim 47
Testing effectiveness (Phase 2)Study completedNCT01603277
What this trial is testing

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Who this might be right for
Moderate-to-Severe Asthma
Humanigen, Inc. 160
Not applicableStudy completedNCT03230188
What this trial is testing

Patterns of Neurocircuitry Activation In Severe Asthma

Who this might be right for
Lung Diseases
University of Wisconsin, Madison 28
Not applicableStudy completedNCT02913092
What this trial is testing

Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients

Who this might be right for
Asthma
Montefiore Medical Center 81
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation